| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 04/26/2000 | EP0994950A2 Dna sequences, expression of said dna sequences, thermopile laccases coded by said dna sequences and the use thereof |
| 04/26/2000 | EP0994949A1 Production of attenuated parainfluenza virus vaccines from cloned nucleotide sequences |
| 04/26/2000 | EP0994948A1 TGF$g(b) RII RECEPTOR NUCLEIC SEQUENCE, CODED PEPTIDE, AND USES |
| 04/26/2000 | EP0994947A1 Mu-1, member of the cytokine receptor family |
| 04/26/2000 | EP0994946A1 Coding sequence haplotypes of the human brca2 gene |
| 04/26/2000 | EP0994945A2 Smad-interacting polypeptides and their use |
| 04/26/2000 | EP0994904A2 AMINO ACID SEQUENCES FOR THERAPEUTICAL AND PROPHYLACTIC APPLICATIONS TO DISEASES DUE TO $i(CLOSTRIDIUM DIFFICILE) TOXINS |
| 04/26/2000 | EP0994900A1 Semaphorin receptors |
| 04/26/2000 | EP0994899A2 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN ENDODERM |
| 04/26/2000 | EP0994728A1 Recombinant antibodies specific for beta-amyloid ends, dna encoding and methods of use thereof |
| 04/26/2000 | EP0994724A1 Methods and compositions for impairing multiplication of hiv-1 |
| 04/26/2000 | EP0684992B1 Method for obtaining an increased production of a producing celline by using a fusion protocol |
| 04/26/2000 | EP0633930B1 In vitro generation of human dendritic cells |
| 04/26/2000 | CN1251614A New EIA test using non-dentured HIV antigen for early detection of HIV infection |
| 04/26/2000 | CN1251610A Novel mouse CXC chemokine receptor |
| 04/26/2000 | CN1251528A Targeted system for removing tumor cells from cell populations |
| 04/26/2000 | CN1251391A Method for obtaining high-productive culture cells of taxianes diterpene |
| 04/26/2000 | CN1051769C Parathyroid hormone analogues, their production method and medicinal composition containing same |
| 04/25/2000 | US6054637 Signal sequences for vacuolar sorting |
| 04/25/2000 | US6054632 Method of making monoclonal antibodies using polymorphic transgenic animals |
| 04/25/2000 | US6054572 Fibronectin binding protein; monoclonal antibody and their use in preventing bacterial adhesion |
| 04/25/2000 | US6054567 Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines |
| 04/25/2000 | US6054560 Mitogen activated protein kinase, FRK |
| 04/25/2000 | US6054559 Interleukin-1 receptor antagonist beta (IL-1raβ) |
| 04/25/2000 | US6054321 Forming three-dimensional structure of a fluorescent protein, constructing model of other fluorescent protein using first as template, making mutants by replacing amino acid(s) within 5 angstroms of any atom of chromophore |
| 04/25/2000 | US6054320 Includes a regent which binds to effector of arachidonic acid release in biopsy sample cells and another reagent for detectably labelling binding agent; for early, accurate diagnosis |
| 04/25/2000 | US6054319 Method and apparatus for growing cells using gas or liquid aphrons |
| 04/25/2000 | US6054317 Mixture of sodium, magnesium, chloride, potassium, calcium, bromine and sulfate ions, and ascorbic acid; will accommodate wide variety of species and cell types, is reliable, convenient to use, and cost effective in its manufacture |
| 04/25/2000 | US6054314 Method for collecting cells from internal organs |
| 04/25/2000 | US6054313 For diagnosis of persistant hyperinsulinemic hypoglycemia of infancy; for screening drugs and antidiabetic agents; for gene therapy |
| 04/25/2000 | US6054311 After thawing, suppporting cells in gas permeable medium of polyfluorinated compound gassed with respiratory gas; to promote normal cell growth and function |
| 04/25/2000 | US6054308 Arginase II |
| 04/25/2000 | US6054293 Polypeptide involved in chemotatic response; screening for modulator proteins involved in nerve cell migration |
| 04/25/2000 | US6054292 T-cell receptor protein |
| 04/25/2000 | US6054284 Immunoreagents reactive with a conserved epitope of human immunodeficiency virus type I (HIV-1) GP120 and methods of use |
| 04/25/2000 | US6054273 Inhibitors of alternative alleles of genes as a basis for cancer therapeutic agents |
| 04/25/2000 | US6054142 Biocompatible devices with foam scaffolds |
| 04/25/2000 | US6054130 Non-splicing variants of gp350/220 |
| 04/25/2000 | US6054122 A foamable fibrin matrix comprising fibrinogen or metabolite and an foaming agent which causes fibrinogen to foam during application of fibrinogen to wounded tissue |
| 04/25/2000 | US6054121 Modulation of immune responses in blood-borne mesenchymal cells |
| 04/25/2000 | CA2155728C Regulated transcription of targeted genes and other biological events |
| 04/25/2000 | CA2019803C Feline interferon and process for production thereof |
| 04/25/2000 | CA1340970C Lipase from gastric mucosa |
| 04/22/2000 | CA2285749A1 Novel proteins from actinobacillus pleuropneumoniae |
| 04/20/2000 | WO2000022167A1 Method for determining transcription factor activity and its technical uses |
| 04/20/2000 | WO2000022151A1 Parvovirus vectors and their use |
| 04/20/2000 | WO2000022146A1 EXPRESSION AND SECRETION OF icIL-1 RECEPTOR ANTAGONIST TYPE II |
| 04/20/2000 | WO2000022144A2 Means and methods for modulating stomata characteristica in plants |
| 04/20/2000 | WO2000022143A2 Protein kinase homologs |
| 04/20/2000 | WO2000022142A2 Cell signaling polypeptides and nucleic acids |
| 04/20/2000 | WO2000022141A2 Specific genetic modification of the activity of trehalose-6-phosphate synthase and expression in a homologous or heterologous environment |
| 04/20/2000 | WO2000022140A1 NUCLEIC ACID MOLECULES WHICH CODE A BRANCHING ENZYME FROM BACTERIA OF THE GENUS NEISSERIA, AND A METHOD FOR PRODUCING α-1,6-BRANCHED α-1,4-GLUCANS |
| 04/20/2000 | WO2000022137A2 Selectively replicating viral vectors |
| 04/20/2000 | WO2000022130A2 Metastatic breast and colon cancer regulated genes |
| 04/20/2000 | WO2000022129A1 Non-endogenous, constitutively activated human g protein-coupled receptors |
| 04/20/2000 | WO2000022126A1 Follistatin-related protein zfsta2 |
| 04/20/2000 | WO2000022125A2 6-protein-coupled receptor-like proteins, polynucleotides encoded by them, and methods of using same |
| 04/20/2000 | WO2000022121A2 Ion channels, in particular vanilloid receptor-like (vr-l) receptor |
| 04/20/2000 | WO2000022120A1 (mbp1) polypeptides capable of interacting with oncogenic mutants of the p53 protein |
| 04/20/2000 | WO2000022113A1 ENZYMATIC SYNTHESIS OF ssDNA |
| 04/20/2000 | WO2000022112A1 Stabilized bioactive peptides and methods of identification, synthesis and use |
| 04/20/2000 | WO2000022111A1 Method for generating diversity |
| 04/20/2000 | WO2000022099A1 Materials and methods for the modification of plant lignin content |
| 04/20/2000 | WO2000022098A1 Porcine oocytes with improved developmental competence |
| 04/20/2000 | WO2000022097A2 Periferal blood mensenchymal precursor cells |
| 04/20/2000 | WO2000022096A2 Chinese hamster ovary cells for producing proteins |
| 04/20/2000 | WO2000022092A2 Materials and methods for the modification of plant cell wall polysaccharides |
| 04/20/2000 | WO2000022000A1 Methods for the production of antibodies to specific regions of cyclosporine and cyclosporine metabolites |
| 04/20/2000 | WO2000021995A1 Treatment of inflammatory disease |
| 04/20/2000 | WO2000021988A2 Human ankyrin family protein |
| 04/20/2000 | WO2000021987A2 A method of identifying modulators of cell surface membrane receptors useful in the treatment of disease |
| 04/20/2000 | WO2000021986A2 Matrix-remodeling genes |
| 04/20/2000 | WO2000021978A2 Laminin 5, 13 and 14 and uses thereof |
| 04/20/2000 | WO2000021976A1 Bone morphogenic protein-induced genes and polypeptides, and their use in diagnostic and therapeutic methods |
| 04/20/2000 | WO2000021557A1 Delta 6 fatty acid desaturase |
| 04/20/2000 | WO2000021555A1 Contraception through antagonizing wnt; oocyte maturation with wnt polypeptide |
| 04/20/2000 | WO2000021551A1 Isolated peptides which bind to hla-b35 molecules |
| 04/20/2000 | WO2000021549A1 A method of inducing or enhancing chondrogenesis with extracellular matrix containing gdf-5 |
| 04/20/2000 | WO2000021456A1 Method and device for preparing a dental implant by immersion in a mesenchymal cell culture |
| 04/20/2000 | WO2000006605A9 Heterominibodies |
| 04/20/2000 | WO2000005343A3 Cell expansion system for use in neural transplantation |
| 04/20/2000 | WO2000003687A3 Potassium channel polypeptide and polynucleotide compositions |
| 04/20/2000 | WO2000003000A3 Serum-free medium for culturing animal cells |
| 04/20/2000 | WO2000002999A3 Medium and matrix for long-term proliferation of cells |
| 04/20/2000 | WO2000001713A9 Diacylglycerol acyl transferase proteins |
| 04/20/2000 | WO2000000622A3 Human oxidoreductase proteins |
| 04/20/2000 | WO2000000506A3 Human proteins having hydrophobic domains and dnas encoding these proteins |
| 04/20/2000 | WO1999064461A3 Monoclonal antibodies, cross-reactive antibodies and method for producing the same |
| 04/20/2000 | WO1999057266A3 Immunosuppression by blocking t cell co-stimulation signal 2 (b7/cd28 interaction) |
| 04/20/2000 | WO1999054463A3 Human k+ ion channel and therapeutic applications thereof |
| 04/20/2000 | WO1999053078A3 Human protease and use of such protease for pharmaceutical applications and for reducing the allergenicity of non-human proteins |
| 04/20/2000 | WO1999053062A3 Isolated sh3 genes associated with myeloproliferative disorders and leukemia, and uses thereof |
| 04/20/2000 | DE19848017A1 Episomally replicating vectors, useful in gene therapy, contain origins of replication and scaffold-matrix attached region sequences but no viral coding sequences |
| 04/20/2000 | CA2675802A1 Use of an immunoglobulin-producing cell line to gererate diversity in a gene or gene product |
| 04/20/2000 | CA2347968A1 Follistatin-related protein zfsta2 |
| 04/20/2000 | CA2347653A1 Novel cell signaling polypeptides and nucleic acids |
| 04/20/2000 | CA2347121A1 (mbp1) polypeptides capable of interacting with oncogenic mutants of the p53 protein |
| 04/20/2000 | CA2347113A1 Human ankyrin family protein |
| 04/20/2000 | CA2346877A1 Specific genetic modification of the activity of trehalose-6-phosphate synthase and expression in a homologous or heterologous environment |
| 04/20/2000 | CA2346775A1 Protein kinase homologs |